Vera Therapeutics, a biotech company developing treatments for serious immunological diseases, will present at the Bank of America Securities 2026 Health Care Conference in Las Vegas on May 13, 2026. The management team will also hold one-on-one investor meetings. Vera's lead product candidate, atacicept, targets autoimmune diseases like IgA nephropathy and lupus nephritis. The company is also developing other therapies including VT-109 and MAU868, focusing on B-cell mediated diseases and BK virus infection in kidney transplant patients. A replay of the presentation will be available for 90 days on Vera Therapeutics' website.
Deere & Company announced a quarterly dividend of $1.62 per share, payable on August 10, 2026. The dividend will be paid to shareholders of record as of June 30, 2026. This dividend declaration reflects the company's ongoing commitment to returning v...
Tesla shares gained as investors reacted to a 67.2% year-over-year increase in European electric vehicle sales and speculation about a potential future merger with SpaceX. Tesla sold 9,169 vehicles in Europe in April, with year-to-date sales up 61.7%...
Modine Manufacturing is pivoting from traditional markets to focus on advanced AI cooling solutions for hyperscale data centers. The company has beaten earnings and revenue estimates for four consecutive quarters, reporting $1.71 earnings per share a...
The global fleet telematics market is projected to grow from $10.42 billion in 2025 to $21.95 billion by 2032, at an 11.2% CAGR. Growth is fueled by increased adoption of advanced telematics in commercial vehicles for operational efficiency, predicti...
Bank of Nova Scotia reported strong Q2 fiscal 2026 results, with adjusted earnings of $1.47 per share beating the $1.46 estimate and revenue of $7.17 billion surpassing expectations. Key segments showed growth: Canadian Banking earnings rose 53%, Int...
